Mirae Asset Global Etfs Holdings Ltd. Guardant Health, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 71,236 shares of GH stock, worth $2.89 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
71,236
Previous 67,180
6.04%
Holding current value
$2.89 Million
Previous $2.05 Million
47.86%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GH
# of Institutions
393Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$491 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$456 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$221 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$209 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$206 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.15B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...